baber/WOPTO huggingface dataset:
Patent NZ-533153-A (NZ)
Title: System and method for measuring stiffness in standing trees
Inventor: HUANG CHIN-LIN
IPC: G01N29/07
Filed: 2004-05-26
Abstract: A non-destructive evaluation system for testing wood products, comprising: a first integrally formed handheld measuring probe having a body that comprises a shaft defining a first impact surface, a spike fixedly coupled to one end of the shaft, a transducer in contact with the spike for detecting a stress wave imparted thereto and outputting a signal indicating the presence of a stress wave, and a handle slideably coupled to the shaft; a second integrally formed handheld measuring probe having a body that comprises a shaft, a spike fixedly coupled to the shaft, a transducer in contact with the spike for detecting a stress wave and outputting a signal indicating the presence of a stress wave, and a handle slideably coupled to the shaft; and an electronic unit comprising a timing device, the electronic unit coupled in electrical communication with the transducer of the first measuring probe and the transducer of the second measuring probe for receiving the outputted signals therefrom; wherein the electronic unit determines the travel time of the stress wave from the transducer of the first probe to the transducer of the second probe.
Patent NZ-533218-A (NZ)
Title: Substituted diketopiperazines as oxytocin antagonists
Inventor: BORTHWICK ALAN DAVID
IPC: C07D401/12
Filed: 2002-12-20
Abstract: Disclosed are compounds of formula (1) wherein the substituents are as described in the specification and processes for making them. Also disclosed are uses of compounds of formula (1) in the manufacture of a medicament for the treatment of one or more diseases or conditions selected from pre-term labour, dysmenorrhea, endometriosis and benign prostatic hyperplasia.
Patent NZ-534502-A (NZ)
Title: Bilayer pharmaceutical tablet comprising the angiotensin II receptor antagonist telmisartan and a diuretic
Inventor: FRIEDL THOMAS
IPC: A61K31/4965
Filed: 2002-01-16
Abstract: A bilayer pharmaceutical tablet is disclosed, which comprises a first layer comprising telmisartan in substantially amorphous form in a dissolving tablet matrix, and comprising a basic agent, and a second layer comprising a diuretic selected from hydrochlorothiazide, furosemide, chlorotalidone, piretanide and amiloride in a disintegrating tablet matrix. A method of producing the bilayer tablet is also disclosed.
Patent NZ-534725-A (NZ)
Title: Wave energy converter system of improved efficiency and survivability
Inventor: CHALMERS PETER DONALD
IPC: F03B13/14
Filed: 2003-02-14
Abstract: A known type of surface wave energy converter comprises a submerged elongated tube supported by, but being vertically movable relative to, an anchored float. The tube vertically reciprocates in response to overpassing surface waves and drives a transducer for generating useful energy. Improvements include: a motion translator between the tube and the transducer for reducing the stroke length of the transducer and magnifying the force transmitted to the transducer; an energy buffer system for limiting the travel of the tube in response to excessively large surface waves; a gravity anchor for the system for absorbing energy from even greater amplitude waves; means for adjusting buoyancy in response to changing conditions, and pressure relief valves for automatically reducing excessive tube driving pressures caused by excessively large overpassing waves. Energy present in tilting movements of the apparatus is optionally captured in horizontally disposed transducers.
Patent NZ-536905-A (NZ)
Title: Laser transponder for disabling a laser-based speed monitor
Inventor: BOGH-ANDERSEN TORBEN
IPC: G01S7/483
Filed: 2003-05-01
Abstract: A laser transponder (1), for disabling a laser-based speed monitor (7) transmitting a monitor laser beam at a moving vehicle, by transmitting a jamming laser beam to the laser-based speed monitor, is disclosed. The laser transponder (1) includes a microprocessor (4) containing software, a monitor signal converter (3), a jamming signal converter (5), and an optical transmitter (6). The monitor laser beam is in the shape of a monitor signal (8; s1; sm) which includes pulse trains that have at least one pulse emitted with a first frequency f1. The jamming laser beam is in the shape of a jamming signal (11; s1; sj) which includes jamming pulse trains that have at least one pulse emitted with a second frequency f3.
Patent NZ-540408-A (NZ)
Title: Aluminium electrowinning cells with metal-based anodes and a fluoride-containing molten electrolyte
Inventor: DE NORA VITTORIO
IPC: C25C3/18
Filed: 2004-02-18
Abstract: A cell for the electrowinning of aluminium comprises a metal-based anode (10) containing at least one of nickel, cobalt and iron is disclosed. The anode (10) may be covered with an applied or an integral hematite-based layer and/or a cerium oxyfluoride-based outermost coating. The cell contains a fluoride-containing molten electrolyte (5) at a temperature below 950 DEG C, in which the anode (10) is immersed and which consists of: 6.5 to 11 weight% dissolved alumina; 35 to 44 weight% aluminium fluoride; 38 to 46 weight% sodium fluoride; 2 to 15 weight% potassium fluoride; 0 to 5 weight% calcium fluoride; and 0 to 5 weight% in total of one or more further constituents. An anode stem (14b) containing nickel and/or iron can be used to suspend the anode (10) in the electrolyte (5) facing a cathode (21,21A,25) that has an aluminium-wettable surface (20), in particular a drained horizontal or inclined surface.
Patent NZ-541088-A (NZ)
Title: Triazine compounds and their use in forming multidimensional libraries for affinity chromatography
Inventor: BURTON STEVEN JAMES
IPC: C07D251/70
Filed: 2003-12-09
Abstract: Disclosed is a compound comprises affinity ligands immobilised on a support matrix, the compound being represented by formula (I). Each Z is the same or different and is formula (a) or -Y, wherein each X is independently selected from -NH- and diaminoalkane, diethylenetriamine or tris(aminoethyl)amine spacers linked to the triazine rings by amine groups, and each Y is the same or different affinity ligand linked to the appropriate triazine ring by an amine group. M is a support matrix, comprising a particulate or non-particulate, soluble or non-soluble, porous or non-porous material. Also disclosed are a method for the production of a library of compounds represented by formula (I) and the use of the compounds for separation, isolation, purification, characterisation, identification, quantification or discovery of peptides and proteins.
Patent NZ-544759-A (NZ)
Title: Assembly of drink dispenser and container provided with a pressure medium reservoir
Inventor: PAKKERT ENGBERT HERMANNES
IPC: B67D1/00
Filed: 2004-07-15
Abstract: An assembly of a drink dispenser (2) provided with a chamber (4) for accommodating a container containing carbonated drink, in particular beer, is disclosed. The assembly includes a lid (5) for closing the chamber, a dispensing head (13) for opening and closing a dispensing line (10), and a container (3) containing carbonated drink provided with a drink dispensing opening (8). A dispensing line (10) connects the drink dispensing opening with the dispensing head. The container is provided with a pressure medium feed opening (21) and a reservoir (17) containing a pressure medium such as CO2. The reservoir has a pressure line coupling (20) coupled to a reservoir connector (23) that is connected to one end of a pressure line (22) provided with the lid. At the other end of the pressure line is a pressure medium feed opening (21) of the container. The reservoir connector and the pressure medium feed connector are brought into fluid-tight engagement with the pressure line coupling and the pressure medium feed opening, respectively, by closing the lid. This arrangement allows simple and rapid connection of a carbonated drink chamber to a pressure reservoir.
Patent NZ-548245-A (NZ)
Title: Docking buffer
Inventor: OTT RAINER
IPC: B65G69/00
Filed: 2004-11-05
Abstract: A docking buffer for attaching to ramps, comprising an elastic damping element (3) that is situated between two U-shaped sections (1, 2) consisting of a hard, shock-proof material. The limbs (4, 5) and (6, 7) of the sections are adjacent to one another and can be displaced in relation to one another, the limbs (4, 5) of one U-shaped section (2) converging at an angle alpha that deviates from 90 degrees in relation to a base surface (9) and the limbs (6, 7) of the other U-shaped section (1) diverging at an angle beta that deviates from 90 degrees in relation to a base plate (8). The opening widths between the ends of the limbs (4, 5) and (6, 7) and the sizes of the angles alpha, beta are selected in such a way that the limbs (4, 5) embrace the limbs (6, 7).
Patent NZ-552396-A (NZ)
Title: Composition containing simvastatin, coenzyme Q10, resveratrol, pantethine and omega-3 fatty acids
Inventor: CAVAZZA CLAUDIO
IPC: A61P3/06
Filed: 2005-07-19
Abstract: Disclosed is a pharmaceutical composition comprising: a) an omega-3 fatty acid (selected from the group consisting of cis 5, 8, 11, 14, 17-eicosapentanoic acid (EPA) and cis 4, 7, 10, 13, 16, 19-docosahexanoic acid (DHA)): from 500 mg to 2 g/day; b) simvastatin: from 10 mg to 40 g/day; c) coenzyme Q10: from 5 mg to 50 mg/day; d) resveratroI: from 1 mg to 5 mg/day; e) policosanols: hexacosanoI: from 5 mg to 15 mg/day; f) pantethine: from 10 mg to 30 mg/day; g) selenium: from 25 mg to 75 mg/day; h) zinc: from 5 mg to 15 mg/day; wherein the composition may be in the form of a food supplement for human or animal use. Also disclosed is the use of the composition for the preparation of a medicament for the treatment of type 2 diabetes and insulin resistance. Additionally, the use of the composition for the preparation of a medicament useful for the treatment of diseases involving insulin resistance, wherein said disease is selected from the group consisting of type 2 diabetes and its complications, syndrome X, polycystic ovary syndrome, obesity, hypertension, hyperlipidaemias and hypercholesterolaemias is further disclosed.
Patent NZ-556017-A (NZ)
Title: G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
Inventor: FYFE MATTHEW COLIN THOR
IPC: A61K31/44
Filed: 2005-12-23
Abstract: Disclosed are G-protein coupled receptor (GPCR) agonist compounds of formula (IA), wherein the variables are as defined in the specification and pharmaceutically acceptable salts thereof, which are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes.
Patent NZ-556402-A (NZ)
Title: Hair extension method and apparatus
Inventor: RUSSO SARINA
Filed: 2007-07-09
Abstract: A weft hair extension apparatus (200) and a method of attaching the same to scalp hair (212) of a person (214) are disclosed. The method includes the steps of: passing strands of scalp hair through a plurality of beads (232) that are affixed to or integral with a seam (216) of the extension apparatus; passing strands of scalp hair and strands of extension hair (218) through a plurality of deformable locking beads (224) (where the deformable locking beads are not affixed to or integral with the weft hair apparatus); and deforming the plurality of deformable locking beads so that the strands of scalp and the strands of extension hair are then held captive within the deformed locking bands.
Patent NZ-560605-A (NZ)
Title: Curtain locking system, typically for truck or trailer, with latching of free hanging hook(s)
Inventor: KING LINDSAY ALEXANDER
IPC: B60P7/04
Filed: 2006-01-19
Abstract: The curtain locking mechanism (10) includes a hook (12) and latch assembly (14). The mechanism (10) is adapted for installation below the base (16) of a truck or trailer. The latch assembly (14) comprises a drive means (18) in the form of a pneumatic ram, adapted to pivot a shaft (20). The ram (18) is pivotally connected to a lever arm (22) of the shaft (20). The latch assembly (14) further comprises a crank (24) on the shaft (20) adjacent the hook (12). The hook (12) is attached to the curtain (26) by means of a length adjustment device (28) and a curtain strap (30). The curtain strap (30) is attached at one end to the curtain (26), such as by welding or stitching, and attached to the hook (12) at the other end via the adjustment device (28). In use, the latch assembly (14) can be moved between a locked configuration and an unlocked configuration. In the locked configuration, the latch assembly (14) engages the hook (12). In the unlocked configuration, the latch assembly (14) is disengaged from the hook (12).
Patent NZ-569729-A (NZ)
Title: Compounds for the treatment of metabolic disorders
Inventor: SHARMA SHALINI
IPC: A61K31/12
Filed: 2007-01-22
Abstract: Disclosed is the use of a biologically active agent in the manufacture of a medicament for treatment of a condition selected from the group consisting of insulin resistance syndrome, diabetes including Type I Diabetes and Type II Diabetes, and polycystic ovary syndrome; or for the treatment or reduction in the chance of developing atherosclerosis, arteriosclerosis, obesity, hypertension, hyperlipidemia, fatty liver disease, nephropathy, neuropathy, retinopathy, foot ulceration or cataracts associated with diabetes; or for the treatment of a condition selected from the group consisting of hyperlipidemia, cachexia, and obesity; wherein the agent is a compound of formula (I) and the variables are as disclosed in the description. Also disclosed are 2,6-dihydroxybenzyloxy phenyl acid or ester compounds of formula (I) and pharmaceutical compositions comprising a compound of formula (I).
Patent NZ-571290-A (NZ)
Title: Electrically pumped broadly tunable mid-infrared lasers based on quantum confined transition metal doped semiconductors
Inventor: MIROV SERGEY
IPC: H01S3/16
Filed: 2007-03-12
Abstract: Disclosed is a semiconductor gain medium in an electrically pumped broadly tunable midinfrared laser, the semiconductor gain medium comprising doped quantum confined host material (DQCH) structured to have characteristic spatial dimension of the confinement tuned to enable the overlap of the discrete levels of the host and impurity ions and efficient energy transfer from the separated host carriers to the impurity, wherein: said DQCH material has the formula TM:MeZ and/or MeX2Z4, wherein Me is selected from the group consisting of Zn, Cd, Ca, Mg, Sr, Ba, Hg, Pb, Cu, Al, Ga, In; Z is selected from the group consisting of S, Se, Te, O, N, P, As, Sb and their mixtures; X being selected from the group consisting of Ga, In, and Al; and TM is selected from the group consisting from V, Cr, Mn, Fe, Co, and Ni, and wherein said characteristic spatial dimension of the confinement is less than about 100 nanometers.
Patent NZ-573719-A (NZ)
Title: Production of ultrapure eicosapentaenoic acid and polar lipids from largely heterotrophic culture of nitzschia laevis
Inventor: GEIRINGER KARL THOMAS
IPC: C12P1/00
Filed: 2007-07-05
Abstract: A process to increase the amount of polar lipids with at least one eicosapentaenoic acid (EPA) side chain with respect to the amount of neutral lipids with at least one EPA side chain in a biomass. The process includes culturing a micro-organism capable of producing EPA in a culture phase in which the cells are grown under conditions in which organic carbon is used as an energy source. The illumination is controlled at a level corresponding to an average photosynthetically active irradiance inside the culture of about 1-40 micromol photons per square metre per second. The micro-organism can be the marine single-celled diatom Nitzschia laevis.
Patent NZ-580452-A (NZ)
Title: A lamp for illuminating a licence plate of a vehicle that clips onto an existing lamp assembly
Inventor: SINCLAIR PAUL GRAHAM
IPC: B60Q1/26
Filed: 2009-10-16
Abstract: An auxiliary or optional vehicle lamp assembly (10) is disclosed. The assembly (10) is configured to engage with an existing lamp (80a, 80b) so that light may be cast along the side of a vehicle, to illuminate an insignia or a number plate (100) for example. The assembly (10) may be clipped into place on the existing lamp (80a, 80b) and held there by a deflectable arm engaged in a recess.
Patent NZ-582950-A (NZ)
Title: Process for the preparation of alfuzosin hydrochloride
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: C07D405/12
Filed: 2008-08-01
Abstract: Disclosed is a process for preparing alfuzosin or a salt thereof comprising (a) condensing 4-amino-2-chloro-6,7-dimethoxyquinazoline with 3-methylaminopropionitrile in the presence of a polar aprotic solvent selected from the group consisting of diglyme, dimethyl formamide, t-butanol, hexamethylphosphoramide or mixtures thereof to form N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-2cyanoethylamine (b) hydrogenating the N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-2cyanoethylamine using a hydrogenating agent under a pressure of less than 10 kilograms per centimetre squared to form N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methylpropylenediamine and (c) converting tetrahydrofuroic acid (VI) to an intermediate form (VII) and condensing the intermediate form (VII) with the N-(4-amino-6,7-dimethoxyquinazol-yl)- N-methylpropylenediamine or with the acid addition salt thereof to yield alfuzosin base wherein R is defined in the specification.
Patent NZ-583450-A (NZ)
Title: Substituted indazole derivatives active as kinase inhibitors
Inventor: LOMBARDI BORGIA ANDREA
IPC: A61K31/33
Filed: 2008-07-08
Abstract: Disclosed are indazol benzamide compounds represented by general formula (I) and processes for making the compounds of formula (I). Examples of the compounds of formula (I) include: N-(5-benzyl-1H-indazol-3-yl)-4-(4-methyl-piperazin-1-yl)-benzamide; N-[5-(3-fluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-benzamide; and N-[5-(2,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)benzamide; The compounds are used as kinase inhibitors.
Patent NZ-584363-A (NZ)
Title: Drug formulations of Rotigotine which comprise the thermodynamically stable polymorphic form 2
Inventor: WOLFF HANS-MICHAEL
IPC: A61K31/381
Filed: 2008-11-25
Abstract: Disclosed is a rotigotine drug substance comprising at least 5% of a polymorphic form (II) of rotigotine ((-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]-amino]-1-naphthalenol) having at least one of: a X-ray powder diffraction spectrum comprising at least one peak at the following °2q angles (± 0.2): 12.04, 13.68, 17.72, 19.01; a Raman spectrum comprising at least three peaks at the following wave numbers (± 3 cm-1): 226.2, 297.0, 363.9, 710.0, 737.3, 743.3, 750.8, 847.3, 878.3, 1018.7, 1075.6, 1086.2, 1214.3, 1255.1, 1278.2, 1330.7, 1354.3, and 1448.7; a DSC peak with a Tonset at 97oC ± 2°C measured with a heating rate of 10oC/min; a melting point of 97oC ± 2°C. Also disclosed is a pharmaceutical composition which comprises a rotigotine drug substance as defined above, and at least one pharmaceutically acceptable excipient, for the treatment of a patient suffering from a disease sensitive to the treatment with D2 receptor agonists, wherein said disease is selected from Parkinson's Disease, Parkinson's plus syndrome, depression, fibromyalgia, restless-legs syndrome, and/or dopaminergic neuron loss.
Patent NZ-587078-A (NZ)
Title: Increased ethanol production by thermophilic bacteria
Inventor: BAGHAEI-YAZDI NAMDAR
IPC: C12P7/06
Filed: 2009-02-12
Abstract: A fermentation process to produce ethanol from sugars. The process comprises supplying a thermophilic bacterium that lacks lactate dehydrogenase activity, with sugars, and maintaining the redox balance of the bacterium through supplying glycerol to minimise acetate production and maximise the ethanol production. The bacterium can be Bacillus stearothermophilus strain LLD-R (NCIMB 12403) or strain LLD-15 (NCIMB 12428) or Geobacillus thermoglucosidasius.
Patent NZ-589797-A (NZ)
Title: Absorptive article and sanitary napkin with dual density endothermic pad for cooling
Inventor: NODA YUKI
IPC: A61F13/15
Filed: 2009-05-25
Abstract: Disclosed is an absorbent article or sanitary napkin to provide a cooling sensation. The article comprises a liquid permeable top sheet, a liquid impermeable back sheet, and an absorber interposed between the top sheet and the back sheet. An endothermic material is disposed inside the absorber on a side facing the back sheet, and a depression and a projection are formed on a surface of the top sheet facing a human body. A basis weight in the projection is larger than a basis weight in the depression. An intermediate sheet of a nonwoven fabric is interposed between the top sheet and the absorber, in which a first density region and a second density region are formed to spread out in a planar direction, and a fibre density of the second density region is lower than a fibre density of the first density region.
Patent NZ-590467-A (NZ)
Title: A sorbent for a dialysis device where the pressure drop over across the layer is dependent of the size of the particles in the primary layer of immbolized uremic toxin-treating enzyme particles intermixed with cation exchange particles
Inventor: BLUCHEL CHRISTIAN GERT
IPC: A61M1/16
Filed: 2009-06-22
Abstract: 590467 Disclosed is a sorbent for removing metabolic waste products from a dialysis liquid. The sorbent comprises a primary layer of immobilized uremic toxin-treating enzyme particles intermixed with cation exchange particles. The primary layer is arranged within the sorbent such that when in use, the pressure drop of the dialysate across the primary layer is dependent on the size of said cation exchange particles. The sorbent comprises a secondary layer of cation exchange particles and a tertiary layer of anion exchange particles intermixed with organic compounds absorber particles, where the secondary layer is disposed between said primary and said tertiary layer.
Patent NZ-593439-A (NZ)
Title: A simulated cigarette with a breath-activated valve
Inventor: HEARN ALEX
IPC: A24F42/60
Filed: 2009-12-23
Abstract: 593439 Disclosed is a simulated cigarette device with a substantially cylindrical shape comprising a reservoir of a pressurised composition including an inhalable substance and a propellant, a refill valve in communication with the reservoir via which the reservoir is refilled and a breath-activated valve to selectively control the flow through a reservoir outlet and hence through an inhaling outlet in the device. The size of the reservoir, the pressure within the reservoir and the size of the reservoir outlet at its narrowest point are arranged so that, when the breath-activated valve is fully opened, the reservoir will discharge in less than 30 seconds.
Patent NZ-594369-A (NZ)
Title: Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
Inventor: WOLLIN STEFAN-LUTZ
IPC: A61K31/22
Filed: 2007-07-03
Abstract: 594369 Disclosed is a pharmaceutical composition and a combination product comprising Roflumilast also known as 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide; Rosuvastatin also known as (3R,5R)-7-{ 4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl} -3,5-dihydroxyheptanoic acid; and a pharmaceutically acceptable auxiliary. In the combination product the two actives are adapted for simultaneous or sequential administration. Also disclosed is the process for making the composition and the use of the composition for the manufacture of a medicament for the treatment of an inflammatory pulmonary disease.